$80MSeries A, 9 June 2025
Funds to take lead candidate MOS118 through Phase 2.
- Amount
- $80M
- Stage
- Series A
- Announced
- 9 June 2025
- Lead
- EQT Life Sciences
- Other investors
- Pivotal bioVenture Partners, Forbion, Broadview Ventures, Norwest
- Use of funds
- Funds to take lead candidate MOS118 through Phase 2.
- Checked
- Announced by the company
- Sources
- Mosanna Therapeutics raises $80M Series A forbion.com
Mosanna Therapeutics raises $80M Series A techstartups.com